MEN with terminal prostate cancer could benefit from a new drug.
Lutetium, which boosted survival by four months in those whose disease had spread, is safe and effective to use.
It was approved by The Medicines and Healthcare Regulatory Agency.
The drugs watchdog is set to decide whether to recommend an NHS rollout in the autumn.
More than 52,000 men a year are diagnosed with prostate cancer and 12,000 die.
Around 3,500 develop advanced disease that does not respond to routine treatment.
READ MORE IN MEN’S HEALTH
I’m a doctor – here’s the 5 common habits that are bad for your penis
How your LEG pain could actually be a sign of common cancer in young people
Lutetium, given intravenously, binds to cancer cells to deliver a radioactive payload that destroys the tumour.
Prof Johann de Bono, of West London’s Royal Marsden Hospital, said: “This is a major clinical advancement.”
Most read in The Sun
Idiot parked DIRECTLY in front of my drive – everyone's saying the same thing
Ekin-Su signs biggest fashion deal in Love Island history worth over £1m
Carol Vorderman appears to post NAKED TikTok video during holiday in Portugal
Mum, 40, & her dad, 78, killed in crash that's left her daughter critical
Source: Read Full Article
